TSE:4523Pharmaceuticals
Eisai (TSE:4523) Stock Could Be 21.8% Undervalued After UK Investment Backing
Eisai (TSE:4523) has drawn fresh attention after securing support from the UK Government’s Life Sciences Innovation and Manufacturing Fund for new investment in its UK research, development, and manufacturing operations.
See our latest analysis for Eisai.
Despite support for Eisai’s UK investment plans, recent share price performance has been weak. The stock is down 17.11% year to date on a share price basis, and the 5 year total shareholder return is also negative. This suggests sentiment...